Kariman Chaba

Affiliations

Centre de Recherche des Cordeliers, INSERM, CNRS, Université de Paris, Sorbonne Université, USPC, Equipe labellisée Ligue Nationale Contre le Cancer, SIRIC CARPEM, Paris, France.

Réseau de co-auteurs

Julien Taieb 1 collaboration

Valérie Taly 1 collaboration

Julie Henriques 1 collaboration

Camille Bourreau 1 collaboration

Laurent Mineur 1 collaboration

Jaafar Bennouna 1 collaboration

Jérôme Desrame 1 collaboration

Christophe Louvet 1 collaboration

Céline Lepere 1 collaboration

May Mabro 1 collaboration

Joëlle Egreteau 1 collaboration

Olivier Bouche 1 collaboration

Claire Mulot 1 collaboration

Katia Hormigos 1 collaboration

Thibault Mazard 1 collaboration

Aimery de Gramont 1 collaboration

Dewi Vernerey 1 collaboration

Thierry André 1 collaboration

Pierre Laurent-Puig 1 collaboration

Mario Jreige 1 collaboration

Igor Letovanec 1 collaboration

Stephanie Renaud 1 collaboration

Sylvie Rusakiewicz 1 collaboration

Valerie Cristina 1 collaboration

Solange Peters 1 collaboration

Thorsten Krueger 1 collaboration

Laurence de Leval 1 collaboration

Lana E Kandalaft 1 collaboration

Marie Nicod-Lalonde 1 collaboration

Pedro Romero 1 collaboration

John O Prior 1 collaboration

George Coukos 1 collaboration

Niklaus Schaefer 1 collaboration

S Rusakiewicz 1 collaboration

S Tyekucheva 1 collaboration

S Tissot-Renaud 1 collaboration

K Chaba 1 collaboration

M Imbimbo 1 collaboration

F Benedetti 1 collaboration

R Kammler 1 collaboration

J Hornfeld 1 collaboration

E Munzone 1 collaboration

L Gianni 1 collaboration

B Thurlimann 1 collaboration

I Láng 1 collaboration

G Pruneri 1 collaboration

K P Gray 1 collaboration

M R Regan 1 collaboration

S Loi 1 collaboration

M Colleoni 1 collaboration

G Viale 1 collaboration

L Kandalaft 1 collaboration

G Coukos 1 collaboration

Giuseppe Curigliano 1 collaboration

Kariman Chaba

Affiliations

Publications (3)

Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a

Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.

Réseau de co-auteurs